Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03220607
Other study ID # 2016/5
Secondary ID
Status Completed
Phase N/A
First received July 14, 2017
Last updated September 2, 2017
Start date October 15, 2016
Est. completion date September 1, 2017

Study information

Verified date September 2017
Source Kanuni Sultan Suleyman Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To evaluate the performance of uterocervical angle (UCA) in the prediction of second trimester terminations.


Description:

Medical termination of pregnancy is a common procedure in obstetrics. In recent years, uterocervical angle (UCA) emerged as a new ultrasound parameter in the prediction of labor. Dziadosz et al concluded that the performance of UCA was even better than the cervical length in their cohort. A wide UCA during second trimester shown to have an increased risk of preterm labor and narrow angle was less likely to have labor.

The investigators are aimed to investigate predictive role of both cervical length and UCA in the termination of second trimester pregnancy.The investigators focused on nulliparous women who are taking misoprostol for the cervical preparation and aim to measure their UCA.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date September 1, 2017
Est. primary completion date August 30, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Nulliparous singleton pregnancy

- no previous systemic illnesses

Exclusion Criteria:

- abnormal Pap smear

- previous cesarean section

- history of dilatation and curettage (D&C)

- history of LEEP and cervical conization

Study Design


Related Conditions & MeSH terms


Intervention

Other:
uterocervical angle
uterocervical angle is the angle between lower segment of uterus and cervix

Locations

Country Name City State
Turkey Kanuni SSTRH Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary uterocervical angle the angle between the lower segment of uterus and cervix once at the beginning of enrollment
See also
  Status Clinical Trial Phase
Completed NCT03134183 - 24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E Phase 4
Completed NCT04824118 - Clotting Parameters After Medical Abortion
Completed NCT00382538 - Mifepristone and Mid-Trimester Termination of Pregnancy N/A
Recruiting NCT03106389 - Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy Phase 4
Recruiting NCT05322252 - Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial Phase 4
Completed NCT05469594 - Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Completed NCT00495560 - A Pilot Study of Priming Before Induction Termination of Pregnancy N/A
Completed NCT05099991 - Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion N/A
Completed NCT06207539 - Induction of Abortion in the Second Trimester Early Phase 1